Main menu

Long-read sequencing identifies disease-causing variation in difficult-to-study genomic regions


Around 50% of genetic disease remain undiagnosed with regards to their underlying genetic abnormality, despite extensive genetic testing. Danny will discuss the future potential of nanopore sequencing technology to improve this diagnostic rate, demonstrating how on-device targeted sequencing (adaptive sampling) could be used to identify and phase complex disease-causing variants and simultaneously detect abnormal methylation status.

Authors: Danny Miller

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag